Syncona leads £32 million financing in Azeria
LONDON: Syncona Ltd has announced a new portfolio company, Azeria Therapeutics (Azeria) in a £32 million Series B financing in which Syncona has committed £29.5 million alongside existing investor the…
Aurobindo completes acquisition of marketed portfolio from Spectrum Pharmaceuticals
MUMBAI: Aurobindo Pharma Limited has completed the acquisition of marketed portfolio from Spectrum Pharmaceuticals, a bourse filing said on Saturday. Aurobindo Pharma Limited had earlier announced proposed acquisition of seven…